Skip to main content
Gut logoLink to Gut
letter
. 1993 Nov;34(11):1646–1648. doi: 10.1136/gut.34.11.1646-b

Helicobacter pylori positive resistant duodenal ulcers.

M Guslandi
PMCID: PMC1374444  PMID: 8244159

Full text

PDF
1646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan K. D., Naesdal J., Bianchi Porro G., Petrillo M., Lazzaroni M., Hinchliffe R. F., Thompson M., Morris P., Daly M. J., Carroll N. J. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut. 1991 Apr;32(4):435–438. doi: 10.1136/gut.32.4.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dorval E. D., Loulergue J., Barbieux J. P., Metman E. H., de Muret A. Helicobacter pylori et maladie ulcéreuse duodénale. Résultats à long terme d'une tri-thérapie sucralfate-antibiotiques. Gastroenterol Clin Biol. 1991;15(11):863–864. [PubMed] [Google Scholar]
  3. Guslandi M. More about refractory duodenal ulcers. Gut. 1984 Dec;25(12):1433–1434. doi: 10.1136/gut.25.12.1433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Heatley R. V. Review article: the treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 1992 Jun;6(3):291–303. doi: 10.1111/j.1365-2036.1992.tb00051.x. [DOI] [PubMed] [Google Scholar]
  5. Wagner S., Gebel M., Haruma K., Bär W., Lange P., Freise J., Gladziwa U., Schmidt F. W. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori. Gut. 1992 Feb;33(2):179–183. doi: 10.1136/gut.33.2.179. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES